Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer.
Suri A, Bailey AW, Tavares MT, Gunosewoyo H, Dyer CP, Grupenmacher AT, Piper DR, Horton RA, Tomita T, Kozikowski AP, Roy SM, Sredni ST.
Suri A, et al. Among authors: sredni st.
Int J Mol Sci. 2019 Apr 29;20(9):2112. doi: 10.3390/ijms20092112.
Int J Mol Sci. 2019.
PMID: 31035676
Free PMC article.